Jessica Edgar Morris joined Tonix Pharmaceuticals in September 2013 and currently serves as the Chief Operating Officer. Ms. Morris has over 8 years of experience in drug development and over 10 years of experience in finance and investing, at both private and publicly traded companies. She was previously a Vice President at Zhong Rong Group, a family office in NYC, where she oversaw the firm’s investment strategy and asset allocations. Prior to Zhong Rong Group, Ms. Morris worked at American Capital, formerly a publicly traded private equity firm and global asset manager, where she sourced and underwrote investments in companies across a range of industries including healthcare. Ms. Morris also worked in an investment capacity at Calvert Street Capital Partners, a private equity firm in Baltimore, MD, as well as Silicon Valley Bank, a senior debt lender to technology and life science companies. Ms. Morris began her career at Deutsche Bank as an investment banking financial analyst. Ms. Morris is also a classically trained violinist. She received a BS in Commerce and a BA in Music from the University of Virginia, where she was an Echols Scholar.